Sponsor or institution
Clinical trials and research at Biokin (Shanghai) Biopharmaceutical Co., Ltd.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Biokin (Shanghai) Biopharmaceutical Co., Ltd. that are recruiting, in China. By phase: Phase 1 (2), Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BL-M14D1 with Atezolizumab for extensive-stage small cell lung cancer | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Jun 17, 2026 |
| BL-M05D1 vs investigator's choice in CLDN 18.2-positive advanced gastric/GEJ cancer | Phase 3 | Beijing, Beijing Municipality | Recruiting | Apr 8, 2026 |
| Evaluating BL-M14D1 for advanced small cell lung cancer and other solid tumors | Phase 1 | Shanghai, Shanghai Municipality | Recruiting | Jul 17, 2024 |
| Evaluating BL-M05D1 for advanced solid tumors | Phase 1 | Beijing, Beijing Municipality | Recruiting | Apr 5, 2024 |
All recruiting trials (4)
-
BL-M14D1 with Atezolizumab for extensive-stage small cell lung cancer
This phase 2 trial tests whether adding BL-M14D1 to atezolizumab helps people with extensive-stage small cell lung cancer live longer or well enough to continue treatment.
-
BL-M05D1 vs investigator's choice in CLDN 18.2-positive advanced gastric/GEJ cancer
This phase 3 study tests BL-M05D1 against the treating physician’s chosen therapy in adults with CLDN 18.2-positive advanced gastric or GEJ cancer after first-line treatment.
-
Evaluating BL-M14D1 for advanced small cell lung cancer and other solid tumors
This study is testing a new treatment called BL-M14D1 to see if it can help people with advanced small cell lung cancer and other solid tumors who have run out of other treatment options.
-
Evaluating BL-M05D1 for advanced solid tumors
This study is testing a new treatment called BL-M05D1 to see if it is safe and effective for people with advanced solid tumors who have run out of other treatment options.
Quick answers
How many clinical trials run by Biokin (Shanghai) Biopharmaceutical Co., Ltd. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.